뒤로
Theralink Technologies Inc(THER) 가격
THER 주가 차트
THER 수입
Theralink Technologies Inc
$0
0%
$0
종가: Feb 06, 16:00:00 GMT-5
$0
0%
$0
애프터마켓: Feb 06, 20:00:00 GMT-5
Earnings FAQ
THER의 최근 주당순이익(EPS)은 예상과 비교하여 어떤가요?
Theralink Technologies Inc THER의 지난 분기 매출 실적은 어땠나요?
Theralink Technologies Inc의 매출 추정치는 얼마인가요?
Theralink Technologies Inc의 수익 품질 점수는 얼마인가요?
Theralink Technologies Inc는 언제 수익을 보고하나요?
Theralink Technologies Inc의 예상 수익은 얼마인가요?
Theralink Technologies Inc은 수익 기대치를 충족했나요?
주요 통계
이전 종가
$0.0001
시가
$0.001
일일 범위
$0.0001 - $0.001
52주 범위
$0.0001 - $0.001
거래량
110
평균 거래량
0
EPS(TTM)
-0.00
배당수익률
--
시가총액
$615.1K
THER란 무엇인가요?
Theralink Technologies, Inc. is a precision medicine company, which engages in the development of novel cancer immunotherapy products. The company is headquartered in Baton Rouge, Louisiana and currently employs 16 full-time employees. The company went IPO on 2007-04-23. The firm's technology, through its patented phosphoprotein and protein biomarker platform and lab developed tests (LDTs), targets multiple areas of oncology and drug development. Its LDT, the Theralink Assay for Breast Cancer, is utilized by oncologists across the United States to assist in making the targeted treatment plan for their patients with advanced breast cancer. The firm is also working on a second assay for advanced breast cancer that is planned to be pan-tumor for solid tumors across multiple tumor types, such as ovarian, endometrial, liver, head and neck, colorectal, lung, and prostate, among others. The company provides precision oncology data through its Theralink Reverse Phase Protein Array assays to assist the biopharmaceutical industry and clinical oncologists in identifying likely responders and non-responders to both Food and Drug Administration approved and investigational drug treatments.